Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,211.20
(
0.00%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
94.24
(
-2.84%
)
Bitcoin
75,826.70
(
-0.02%
)
News Focus
News Focus
Post# of 405225
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

loanranger

Send PM Follow Ignore
Followers 210
Posts 32744
Boards Moderated 1
Alias Born 06/30/2009

loanranger

Member Level

Re: LIVED post# 371140

Friday, 08/20/2021 9:53:50 AM

Friday, August 20, 2021 9:53:50 AM

Post# of 405225
"Additional work tied to starting, in 2022, a planned Phase 3 study of Brilacidin in Oral Mucositis is also in progress."

Don't know why you left this out...same May PR, previous sentence:
"Development work related to the formulation and manufacture of Brilacidin in capsule form is underway to support our Phase 2 trial in Ulcerative Colitis planned to commence this year."

I'm tryin ta think but nuttin happens......Curly

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote